[D-Trp6]-LH-RH structure
|
Common Name | [D-Trp6]-LH-RH | ||
---|---|---|---|---|
CAS Number | 57773-63-4 | Molecular Weight | 1311.449 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C64H82N18O13 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of [D-Trp6]-LH-RHTriptorelin is a GnRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo: (1) Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GnRHR-I expression of female rats, especially in late-growing follicles.(2) Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins. |
||||
Effect of [D-Trp6]-LH-RH |
Name | triptorelin |
---|---|
Synonym | More Synonyms |
Description | Triptorelin is a GnRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo: (1) Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GnRHR-I expression of female rats, especially in late-growing follicles.(2) Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C64H82N18O13 |
Molecular Weight | 1311.449 |
Exact Mass | 1310.630859 |
PSA | 487.92000 |
LogP | -0.41 |
Index of Refraction | 1.723 |
Storage condition | −20°C |
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H360 |
Precautionary Statements | P201-P308 + P313 |
Personal Protective Equipment | Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges |
Hazard Codes | T: Toxic; |
Risk Phrases | R60 |
Safety Phrases | 53-22-36/37/39-45 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
Arch. Gynecol. Obstet. 287(3) , 447-53, (2013) To evaluate the changes in the volume of rectovaginal endometriotic nodules infiltrating the rectum during 12-month treatment with hormonal therapies.This prospective, non-randomized, self-controlled ... |
|
Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma: 1-year follow-up of a prospective randomized trial.
J. Clin. Oncol. 31(7) , 903-9, (2013) To assess the efficacy of gonadotropin-releasing hormone agonist (GnRHa) in preventing chemotherapy-induced ovarian failure in patients treated for Hodgkin or non-Hodgkin lymphoma within the setting o... |
|
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.
N. Engl. J. Med. 371(2) , 107-18, (2014) Adjuvant therapy with an aromatase inhibitor improves outcomes, as compared with tamoxifen, in postmenopausal women with hormone-receptor-positive breast cancer.In two phase 3 trials, we randomly assi... |
5-Oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolylglycinamide |
triptorelinum |
triptorelinum [INN_la] |
Glycinamide, 5-oxo-L-prolyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-tryptophyl-L-leucyl-L-arginyl-L-prolyl- |
triptoreline |
TRIPORELIN |
MFCD00167541 |
triptorelina |
TRIPTORELIN AMIDE |
UNII:9081Y98W2V |
Triptorelin |
TRIPTORELIN PAMOATE |
Decapeptyl |